Therapeutic applications of transcription factor decoy oligonucleotides.
Mann
M J
MJ
Department of Surgery, and. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Dzau
V J
VJ
D000818:Animals; D001665:Binding Sites / Q000235:genetics; D002352:Carrier Proteins; D018797:Cell Cycle Proteins; D001026:Coronary Artery Bypass; D004268:DNA-Binding Proteins; D050684:E2F Transcription Factors; D015870:Gene Expression; D015316:Genetic Therapy; D006801:Humans; D009838:Oligodeoxyribonucleotides / Q000235:genetics* / Q000378:metabolism / Q000627:therapeutic use*; D056465:Retinoblastoma-Binding Protein 1; D050680:Transcription Factor DP1; D014157:Transcription Factors / Q000037:antagonists & inhibitors* / Q000235:genetics* / Q000378:metabolism
D002352:Carrier Proteins; D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D050684:E2F Transcription Factors; D009838:Oligodeoxyribonucleotides; D056465:Retinoblastoma-Binding Protein 1; D050680:Transcription Factor DP1; D014157:Transcription Factors